| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 484 |
| 1 | RITUXIMAB | 391 |
| 2 | METHOTREXATE SODIUM | 386 |
| 3 | PREDNISOLONE | 378 |
| 4 | PREDNISOLONE ORAL | 378 |
| 5 | PREDNISOLONE ORAL SOLUTION | 378 |
| 6 | TACROLIMUS | 368 |
| 7 | METHOTREXATE | 350 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 318 |
| 9 | TACROLIMUS OINTMENT 0.1% | 318 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SODIUM HYPOCHLORITE | 2 | 0.0077 |
| 1 | DOSTARLIMAB | 18 | 0.0072 |
| 2 | PLERIXAFOR | 10 | 0.0067 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 56 | 0.0067 |
| 4 | BARICITINIB | 20 | 0.0066 |
| 5 | AMIVANTAMAB AND HYALURONIDASE-LPUJ (HUMAN RECOMBINANT) | 2 | 0.0065 |
| 6 | ALCLOMETASONE DIPROPIONATE | 2 | 0.0064 |
| 7 | BEZLOTOXUMAB | 2 | 0.0057 |
| 8 | LISOCABTAGENE MARALEUCEL | 5 | 0.0057 |
| 9 | BENDAMUSTINE HYDROCHLORIDE | 45 | 0.0053 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1102 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 521 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 395 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 378 |
| 4 | Alkylating Drug [EPC] | 369 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 368 |
| 6 | Kinase Inhibitor [EPC] | 321 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 312 |
| 8 | Platinum-based Drug [EPC] | 292 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 273 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 10 | 0.0067 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 26 | 0.0044 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 395 | 0.0040 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 75 | 0.0034 |
| 5 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 7 | 0.0032 |
| 6 | Non-Standardized Pollen Allergenic Extract [EPC] | 2 | 0.0032 |
| 7 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 42 | 0.0032 |
| 8 | Standardized Pollen Allergenic Extract [EPC] | 2 | 0.0031 |
| 9 | Lipopeptide Antibacterial [EPC] | 29 | 0.0031 |